Clinical Trials Browser

Unknown × INDUSTRY × Mesothelioma, Malignant × Clear all

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Phase 1/2 Unknown

186 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

Phase 1 Unknown

30 enrolled

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05598268 2022-10-28

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Phase 1/2 Unknown

74 enrolled

GastrointestinalLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Liver Neoplasms, Lung Neoplasms, Lymphoma

NCT04013334 2022-06-16

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Phase 2 Unknown

12 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03852823 2021-04-30

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

Phase 1 Unknown

192 enrolled

GynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lymphoma

Clinical Trials

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

AMT-151 in Patients With Selected Advanced Solid Tumours

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours